MEI Pharma Net Income

MEI Pharma (MEIP) currently reports a net income of $-61M as of March 2026. That compares with $-32M in the prior-year period — down 92.1% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore MEI Pharma's net income history and peer comparisons.

MEI Pharma's net income decreased from $-32M to $-61M — a 92.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MEI Pharma's net income of $-61M is lower than the Healthcare sector average of $16B. That is roughly 100.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

MEI Pharma reported $-61M in net income as of March 2026. That compares with $-32M in the prior-year period — down 92.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-61M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for MEI Pharma, and consider following MEIP for alerts when major investors trade the stock.